Literature DB >> 25688803

FGFR3 unliganded dimer stabilization by the juxtamembrane domain.

Sarvenaz Sarabipour1, Kalina Hristova2.   

Abstract

Receptor tyrosine kinases (RTKs) conduct biochemical signals upon dimerization in the membrane plane. While RTKs are generally known to be activated in response to ligand binding, many of these receptors are capable of forming unliganded dimers that are likely important intermediates in the signaling process. All 58 RTKs consist of an extracellular (EC) domain, a transmembrane (TM) domain, and an intracellular domain that includes a juxtamembrane (JM) sequence and a kinase domain. Here we investigate directly the effect of the JM domain on unliganded dimer stability of FGFR3, a receptor that is critically important for skeletal development. The data suggest that FGFR3 unliganded dimers are stabilized by receptor-receptor contacts that involve the JM domains. The contribution is significant, as it is similar in magnitude to the stabilizing contribution of a pathogenic mutation and the repulsive contribution of the EC domain. Furthermore, we show that the effects of the JM domain and a TM pathogenic mutation on unliganded FGFR3 dimer stability are additive. We observe that the JM-mediated dimer stabilization occurs when the JM domain is linked to FGFR3 TM domain and not simply anchored to the plasma membrane. These results point to a coordinated stabilization of the unliganded dimeric state of FGFR3 by its JM and TM domains via a mechanism that is distinctly different from the case of another well studied receptor, EGFR.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  juxtamembrane domain; membrane protein dimerization; receptor tyrosine kinases; thermodynamics; transmembrane domain

Mesh:

Substances:

Year:  2015        PMID: 25688803      PMCID: PMC4380549          DOI: 10.1016/j.jmb.2015.02.013

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  44 in total

Review 1.  RTK mutations and human syndromeswhen good receptors turn bad.

Authors:  S C Robertson; J A Tynan; D J Donoghue
Journal:  Trends Genet       Date:  2000-06       Impact factor: 11.639

Review 2.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  Dramatic destabilization of transmembrane helix interactions by features of natural membrane environments.

Authors:  Heedeok Hong; James U Bowie
Journal:  J Am Chem Soc       Date:  2011-07-05       Impact factor: 15.419

4.  FGFR3 transmembrane domain interactions persist in the presence of its extracellular domain.

Authors:  Sarvenaz Sarabipour; Kalina Hristova
Journal:  Biophys J       Date:  2013-07-02       Impact factor: 4.033

Review 5.  Physical-chemical principles underlying RTK activation, and their implications for human disease.

Authors:  Lijuan He; Kalina Hristova
Journal:  Biochim Biophys Acta       Date:  2011-08-05

Review 6.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

Review 7.  The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.

Authors:  Z Vajo; C A Francomano; D J Wilkin
Journal:  Endocr Rev       Date:  2000-02       Impact factor: 19.871

8.  Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.

Authors:  M K Webster; D J Donoghue
Journal:  EMBO J       Date:  1996-02-01       Impact factor: 11.598

Review 9.  Achondroplasia.

Authors:  William A Horton; Judith G Hall; Jacqueline T Hecht
Journal:  Lancet       Date:  2007-07-14       Impact factor: 79.321

10.  Architecture and membrane interactions of the EGF receptor.

Authors:  Anton Arkhipov; Yibing Shan; Rahul Das; Nicholas F Endres; Michael P Eastwood; David E Wemmer; John Kuriyan; David E Shaw
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

View more
  24 in total

1.  Unliganded fibroblast growth factor receptor 1 forms density-independent dimers.

Authors:  Laëtitia Comps-Agrar; Diana Ronai Dunshee; Dan L Eaton; Junichiro Sonoda
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

Review 2.  Piecing it together: Unraveling the elusive structure-function relationship in single-pass membrane receptors.

Authors:  Christopher C Valley; Andrew K Lewis; Jonathan N Sachs
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-01-12       Impact factor: 3.747

Review 3.  The Structural and Functional Diversity of Intrinsically Disordered Regions in Transmembrane Proteins.

Authors:  Rajeswari Appadurai; Vladimir N Uversky; Anand Srivastava
Journal:  J Membr Biol       Date:  2019-05-28       Impact factor: 1.843

4.  A New Method to Study Heterodimerization of Membrane Proteins and Its Application to Fibroblast Growth Factor Receptors.

Authors:  Nuala Del Piccolo; Sarvenaz Sarabipour; Kalina Hristova
Journal:  J Biol Chem       Date:  2016-12-07       Impact factor: 5.157

5.  The SAM domain inhibits EphA2 interactions in the plasma membrane.

Authors:  Deo R Singh; Fozia Ahmed; Michael D Paul; Manasee Gedam; Elena B Pasquale; Kalina Hristova
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2016-10-21       Impact factor: 4.739

6.  The RTK Interactome: Overview and Perspective on RTK Heterointeractions.

Authors:  Michael D Paul; Kalina Hristova
Journal:  Chem Rev       Date:  2018-12-27       Impact factor: 60.622

Review 7.  Fibroblast growth factor signalling in osteoarthritis and cartilage repair.

Authors:  Yangli Xie; Allen Zinkle; Lin Chen; Moosa Mohammadi
Journal:  Nat Rev Rheumatol       Date:  2020-08-17       Impact factor: 20.543

8.  The Epidermal Growth Factor Receptor Forms Location-Dependent Complexes in Resting Cells.

Authors:  Sibel Yavas; Radek Macháň; Thorsten Wohland
Journal:  Biophys J       Date:  2016-11-15       Impact factor: 4.033

9.  Pathogenic Cysteine Removal Mutations in FGFR Extracellular Domains Stabilize Receptor Dimers and Perturb the TM Dimer Structure.

Authors:  Sarvenaz Sarabipour; Kalina Hristova
Journal:  J Mol Biol       Date:  2016-09-03       Impact factor: 5.469

10.  EphA2 Receptor Unliganded Dimers Suppress EphA2 Pro-tumorigenic Signaling.

Authors:  Deo R Singh; Fozia Ahmed; Christopher King; Nisha Gupta; Matt Salotto; Elena B Pasquale; Kalina Hristova
Journal:  J Biol Chem       Date:  2015-09-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.